Bradley Pharmaceuticals (BDY) Received FDA Approval to market Polyphenon E Ointment
Tweet Send to a Friend
Bradley Pharmaceuticals, Inc. (NYSE: BDY) has been notified by MediGene AG (Frankfurt, Prime Standard: MDG) that MediGene received FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
